Kim Woo-Young, Lee Ho-Young
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
FEBS J. 2009 Sep;276(17):4653-64. doi: 10.1111/j.1742-4658.2009.07177.x. Epub 2009 Jul 31.
Formation of new blood vessels is required for the growth and metastasis of all solid tumors. New blood vessels are established in tumors mainly through angiogenesis. Brain tumors in particular are highly angiogenic. Therefore, interventions designed to prevent angiogenesis may be effective at controlling brain tumors. Indeed, many recent findings from preclinical and clinical studies of antiangiogenic therapy for brain tumors have shown that it is a promising approach to managing this deadly disease, especially when combined with other cytotoxic treatments. In this minireview, we summarize the basic characteristics of brain tumor angiogenesis and the role of known angiogenic factors in regulating this angiogenesis, which may be targets of antiangiogenic therapy. We also discuss the current status of antiangiogenic therapy for brain tumors, the suggested mechanisms of this therapy and the limitations of this strategy.
所有实体瘤的生长和转移都需要新血管的形成。肿瘤中的新血管主要通过血管生成来建立。特别是脑肿瘤具有高度的血管生成能力。因此,旨在预防血管生成的干预措施可能对控制脑肿瘤有效。事实上,最近许多关于脑肿瘤抗血管生成治疗的临床前和临床研究结果表明,这是治疗这种致命疾病的一种有前景的方法,尤其是与其他细胞毒性治疗联合使用时。在本综述中,我们总结了脑肿瘤血管生成的基本特征以及已知血管生成因子在调节这种血管生成中的作用,这些可能是抗血管生成治疗的靶点。我们还讨论了脑肿瘤抗血管生成治疗的现状、该治疗的推测机制以及该策略的局限性。